Related Experiment Video

Updated: Apr 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Setmelanotide in Bardet-Biedl Syndrome: A Case Report

Shelby Smith1, Eric Sanfilippo2, Lara Wine Lee2,3

  • 1School of Medicine, University of South Carolina, Columbia, South Carolina, USA.

Pediatric Dermatology
|April 17, 2026
PubMed
Summary

Setmelanotide, a treatment for Bardet-Biedl syndrome, can cause hyperpigmentation. Regular dermatologic screening is recommended to monitor for this and other potential side effects during treatment.

Keywords:
Bardet‐Biedl syndromeMCR4 agonistmelanoma risksetmelanotideskin cancer screening

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K

Related Concept Videos